ClinicalTrials.govpublic full text
Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products
als, autism spectrum disorder, cancer, spasticity, muscle, dyskinetic syndrome, epilepsy, glaucoma, huntington disease, inflammatory bowel disease (ibd), multiple sclerosis, neuropathy, opioid use
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 905117
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.